Abstract
Background: Neuroendocrine neoplasms of the ampulla of Vater (ampullary NEN) have features of both gastrointestinal and pancreato-biliary (PB) NEN. However, the limited number of studies examining ampullary NEN makes it difficult to clarify their unique characteristics. This study aimed to elucidate the clinical characteristics of ampullary NEN. Methods: We enrolled 162 patients with PB-NEN diagnosed at Kyushu University Hospital between 2011 and 2020. Clinical features, pathological diagnoses, treatments, and prognoses were retrospectively analyzed. We also compared ampullary NEN with pancreatic NEN (PanNEN). Results: We analyzed 10 ampullary NEN cases and 149 PanNEN cases. The ampullary NEN cases consisted of 4 cases of neuroendocrine tumor Grade 1 (NET G1), 1 NET G2 (Grade 2), and 5 neuroendocrine carcinomas (NECs). The incidences of NEC and cholangitis were significantly higher in ampullary NEN than in PanNEN. All ampullary NETs had a submucosal tumor-like appearance, as identified by endoscopic ultrasound-guided fine needle aspiration. We treated small NET G1 (<10 mm) with endoscopic papillectomy and large NET G1 with pancreaticoduodenectomy. There were no cases of recurrence after resection. All ampullary NECs presented with the characteristic endoscopic finding of a “crater sign” similar to deep-mining ulcers seen in gastric malignant lymphoma. Four cases underwent surgical resection, and 1 case was unresectable. Two patients who underwent multidisciplinary treatment were maintained without recurrence for over 2 years. Conclusions: Endoscopic findings showed identifiable distinctions between ampullary NETs and NECs.
References
1.
Ito
T
, Igarashi
H
, Nakamura
K
, Sasano
H
, Okusaka
T
, Takano
K
, . Epidemiological trends of pancreatic and gastrointestinal neuroendocrine tumors in Japan: a nationwide survey analysis
. J Gastroenterol
. 2015 Jan
;50
(1
):58
–64
.2.
Dasari
A
, Shen
C
, Halperin
D
, Zhao
B
, Zhou
S
, Xu
Y
, . Trends in the incidence, prevalence, and survival outcomes in patients with neuroendocrine tumors in the United States
. JAMA Oncol
. 2017 Oct
;3
(10
):1335
–42
.3.
Fujimori
N
, Miki
M
, Lee
L
, Matsumoto
K
, Takamatsu
Y
, Takaoka
T
, . Natural history and clinical outcomes of pancreatic neuroendocrine neoplasms based on the WHO 2017 classification; a single-center experience of 30 years
. Pancreatology
. 2020 Jun
;20
(4
):709
–15
.4.
Partelli
S
, Inama
M
, Rinke
A
, Begum
N
, Valente
R
, Fendrich
V
, . Long-term outcomes of surgical management of pancreatic neuroendocrine tumors with synchronous liver metastases
. Neuroendocrinology
. 2015
;102
(1–2
):68
–76
.5.
Crippa
S
, Partelli
S
, Bassi
C
, Berardi
R
, Capelli
P
, Scarpa
A
, . Long-term outcomes and prognostic factors in neuroendocrine carcinomas of the pancreas: morphology matters
. Surgery
. 2016 Mar
;159
(3
):862
–71
.6.
Zhou
B
, Duan
J
, Yan
S
, Zhou
J
, Zheng
S
. Prognostic factors of long-term outcome in surgically resectable pancreatic neuroendocrine tumors: a 12-year experience from a single center
. Oncol Lett
. 2017 Mar
;13
(3
):1157
–64
.7.
Modlin
IM
, Lye
KD
, Kidd
M
. A 5-decade analysis of 13,715 carcinoid tumors
. Cancer
. 2003 Feb
;97
(4
):934
–59
.8.
Beggs
RE
, Kelly
ME
, Eltayeb
O
, Crotty
P
, McDermott
R
, Ridgway
PF
. Large cell neuroendocrine carcinoma of the ampulla of Vater
. JOP
. 2012 Sep
;13
(5
):470
–5
.9.
Zheng
Z
, Chen
C
, Li
B
, Liu
H
, Zhou
L
, Zhang
H
, . Biliary neuroendocrine neoplasms: clinical profiles, management, and analysis of prognostic factors
. Front Oncol
. 2019 Feb
;9
:38
.10.
Lee
KJ
, Cho
JH
, Lee
SH
, Lee
KH
, Park
BK
, Lee
JK
, . Clinicopathological characteristics of biliary neuroendocrine neoplasms: a multicenter study
. Scand J Gastroenterol
. 2017 Apr
;52
(4
):437
–41
.11.
Yang
K
, Yun
SP
, Kim
S
, Shin
N
, Park
DY
, Seo
HI
. Clinicopathological features and surgical outcomes of neuroendocrine tumors of ampulla of Vater
. BMC Gastroenterol
. 2017 May
;17
(1
):70
.12.
Nagtegaal
ID
, Odze
RD
, Klimstra
D
, Paradis
V
, Rugge
M
, Schirmacher
P
, . The 2019 WHO classification of tumours of the digestive system
. Histopathology
. 2020 Jan
;76
(2
):182
–8
.13.
Lee
HS
, Jang
JS
, Lee
S
, Yeon
MH
, Kim
KB
, Park
JG
, . Diagnostic accuracy of the initial endoscopy for ampullary tumors
. Clin Endosc
. 2015 May
;48
(3
):239
–46
.14.
Fujimori
N
, Osoegawa
T
, Lee
L
, Tachibana
Y
, Aso
A
, Kubo
H
, . Efficacy of endoscopic ultrasonography and endoscopic ultrasonography-guided fine-needle aspiration for the diagnosis and grading of pancreatic neuroendocrine tumors
. Scand J Gastroenterol
. 2016
;51
(2
):245
–52
.15.
Nakamura
S
, Matsumoto
T
. Gastrointestinal lymphoma: recent advances in diagnosis and treatment
. Digestion
. 2013
;87
(3
):182
–8
.16.
Shim
KN
, Yang
SK
, Myung
SJ
, Chang
HS
, Jung
SA
, Choe
JW
, . Atypical endoscopic features of rectal carcinoids
. Endoscopy
. 2004 Apr
;36
(4
):313
–6
.17.
Sato
Y
, Hashimoto
S
, Mizuno
K
, Takeuchi
M
, Terai
S
. Management of gastric and duodenal neuroendocrine tumors
. World J Gastroenterol
. 2016 Aug
;22
(30
):6817
–28
.18.
Hatzitheoklitos
E
, Büchler
MW
, Friess
H
, Poch
B
, Ebert
M
, Mohr
W
, . Carcinoid of the ampulla of Vater. Clinical characteristics and morphologic features
. Cancer
. 1994 Mar
;73
(6
):1580
–8
.19.
Defrain
C
, Chang
CY
, Srikureja
W
, Nguyen
PT
, Gu
M
. Cytologic features and diagnostic pitfalls of primary ampullary tumors by endoscopic ultrasound-guided fine-needle aspiration biopsy
. Cancer
. 2005 Oct
;105
(5
):289
–97
.20.
Ogura
T
, Hara
K
, Hijioka
S
, Mizuno
N
, Imaoka
H
, Niwa
Y
, . Can endoscopic ultrasound-guided fine needle aspiration offer clinical benefit for tumors of the ampulla of vater? An initial study
. Endosc Ultrasound
. 2012 Jul
;1
(2
):84
–9
.21.
Uchiyama
Y
, Imazu
H
, Kakutani
H
, Hino
S
, Sumiyama
K
, Kuramochi
A
, . New approach to diagnosing ampullary tumors by magnifying endoscopy combined with a narrow-band imaging system
. J Gastroenterol
. 2006 May
;41
(5
):483
–90
.22.
Makhlouf
HR
, Burke
AP
, Sobin
LH
. Carcinoid tumors of the ampulla of Vater: a comparison with duodenal carcinoid tumors
. Cancer
. 1999 Mar
;85
(6
):1241
–9
.23.
Delle Fave
G
, O’Toole
D
, Sundin
A
, Taal
B
, Ferolla
P
, Ramage
JK
, . ENETS consensus guidelines update for gastroduodenal neuroendocrine neoplasms
. Neuroendocrinology
. 2016
;103
(2
):119
–24
.24.
Scherübl
H
, Jensen
RT
, Cadiot
G
, Stölzel
U
, Klöppel
G
. Neuroendocrine tumors of the small bowels are on the rise: early aspects and management
. World J Gastrointest Endosc
. 2010 Oct
;2
(10
):325
–34
.25.
Clements
WM
, Martin
SP
, Stemmerman
G
, Lowy
AM
. Ampullary carcinoid tumors: rationale for an aggressive surgical approach
. J Gastrointest Surg
. 2003 Sep-Oct
;7
(6
):773
–6
.26.
Yi
H
, Wu
C
, Mou
Y
, Liu
W
, Li
J
, Zhang
Q
, . Successful en bloc resection of papillary neuroendocrine tumors by duodenoscope using endoscopic submucosal dissection method
. Clin Res Hepatol Gastroenterol
. 2012 Oct
;36
(5
):e100
–e103
.27.
Odabasi
M
, Yildiz
KM
, Cengiz
E
, Hasan
AH
, Gunay
E
, Ozkan
E
, . Treatment of ampullary neuroendocrine tumor by endoscopic snare papillectomy
. Am J Case Rep
. 2013 Oct
;14
:439
–43
.28.
Fukasawa
H
, Tounou
S
, Nabetani
M
, Michida
T
. Endoscopic resection of ampullary neuroendocrine tumor
. Intern Med
. 2017
;56
(5
):499
–503
.29.
Matsubayashi
H
, Matsunaga
K
, Sasaki
K
, Yamaguchi
Y
, Hasuike
N
, Ono
H
. Small carcinoid tumor of papilla of the Vater with lymph node metastases
. J Gastrointest Cancer
. 2008
;39
(1–4
):61
–5
.30.
Senda
E
, Fujimoto
K
, Ohnishi
K
, Higashida
A
, Ashida
C
, Okutani
T
, . Minute ampullary carcinoid tumor with lymph node metastases: a case report and review of literature
. World J Surg Oncol
. 2009 Jan
;7
:9
.© 2022 S. Karger AG, Basel
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
2022
You do not currently have access to this content.
